Patient info Search Menu

Staquis 20 mg/g ointment – patient leaflet, side effects, dosage

Contains active substance:

Patient leaflet - Staquis

1. What Staquis is and what it is used for

Staquis contains the active substance crisaborole. Staquis is used on the skin to control the symptoms of mild to moderate atopic dermatitis in adults and children from 2 years of age. Atopic dermatitis, also called atopic eczema, causes skin inflammation, redness, itchiness, dryness, and thickening in people prone to allergies. The ointment should not be used on more than 40% of your body surface area.

Crisaborole, the active substance in Staquis, is thought to work by reducing inflammation and some effects of the immune system (the body’s defences).

2. What you need to know before you use Staquis

Do not use Staquis

  • if you are allergic to crisaborole or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor or pharmacist before using Staquis.

Staquis is not for use in the eyes, mouth, or vagina; therefore, take care not to get this ointment into these areas. If the ointment accidentally gets into these areas, thoroughly wipe off and/or rinse off the ointment with water.

Stop using Staquis immediately and see your doctor if you get an allergic reaction. Symptoms include welts (hives), itching, swelling, and redness that are severe.

Skin reactions where this medicine is applied, such as burning or stinging, may be more likely to occur on sensitive skin areas such as the face and neck.

Children

Staquis has not been studied in children younger than 2 years of age; therefore, it should not be used in this group of children. Speak to your doctor, pharmacist, or nurse.

Other medicines and Staquis

Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.

Some medicines can affect the levels of Staquis in your body. You should inform your doctor if you are taking medicines containing the following active substances:

  • ketoconazole, itraconazole (used to treat fungal infections)
  • erythromycin, clarithromycin, ciprofloxacin (used to treat infections)
  • ritonavir (used to treat HIV)
  • fluvoxamine (used to treat depression).

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. The effects of this medicine in pregnant women are not known; therefore, do not use Staquis in pregnancy unless you have checked with your doctor that you can use it.

It is not known if Staquis passes into the milk after applying it to the skin. The effects of this medicine in breastfed infants are not known; therefore, Staquis should not be used if you are breast-feeding or are planning to breast-feed.

Driving and using machines

Staquis is unlikely to have an effect on your ability to drive and use machines.

Staquis contains propylene glycol

in each gram of ointment.

This medicine contains 90 mg propylene

3. How to use Staquis

Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Use in adults

  • Apply a layer of the ointment twice daily to affected areas of your skin.
  • This medicine can be used on all skin areas except on the scalp.
  • The ointment should only be used on up to 40% of your body surface area.

Wash your hands after applying this medicine, unless it is your hands that are being treated. If someone else applies this medicine to you, they should wash their hands after application.

This medicine can be used twice daily for up to 4 weeks per treatment course. As instructed by your doctor, you can use further treatment course(s) if your atopic dermatitis is not controlled or appears on new areas as long as you do not apply the ointment to more than 40% of your body surface area. If your atopic dermatitis is still there after 12 weeks of therapy, or if your atopic dermatitis gets worse, stop using the medicine and see your doctor.

Moisturisers (emollients) may be used on areas of the skin where Staquis is not applied. Do not use other topical medicines (such as ointments, creams, lotions) on areas of the skin where Staquis is applied without asking your doctor.

Use in children and adolescents

For children 2 years of age and older, and adolescents the instructions for use are the same as for adults.

If you use more Staquis than you should

If too much Staquis has been applied, the excess should be wiped off.

If you forget to use Staquis

If you forget to apply the ointment at the scheduled time, do it as soon as you remember and then continue your normal dosing schedule.

If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Allergic reactions may occur uncommonly. Allergic reactions include severe ms of:

  • hives
  • itching
  • swelling
  • redness.

y and talk with your doctor or

If you have an allergic reaction, stop using this medicine im pharmacist.

Other side effects may include:

Common (may affect up to 1 in 10 people)

  • Skin reactions where this medicine is applied such as pain (burning or stinging), itching, rash, redness, irritation, and hives.

The most common skin reaction, pain (burning or stinging), is usually mild to moderate and generally goes away after several applications.

Uncommon (may affect - Allergic reaction in 100 people) des severe symptoms of hives, itching, swelling, and redness.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the s medicine.

5. How to store Staquis

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the tube and carton after “EXP”. The expiry date refers to the last day of that month.

Do not store above 25 °C. Do not freeze.

Once opened, use the tube within 1 year.

Keep the tube tightly closed.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Staquis contains

  • The active substance is crisaborole.

One g of ointment contains 20 mg of crisaborole.

The other ingredients are paraffin, white soft; propylene glycol (E 1520 [see section 2]); glycerol monostearate 40-55 (Type I); paraffin, hard; sodium calcium edetate.

What Staquis looks like and contents of the pack

Staquis is a white to off-white ointment. It is supplied in 2.5 g, 30 g, 60 g, and 100 g laminate tubes. There are six tubes per carton for the 2.5 g tubes. There is one tube per carton for the 30 g, 60 g, and 100 g tubes. Not all tube sizes may be marketed.

Each tube comes with a tube head with a peel seal, and a white cap closure.

Marketing Authorisation Holder

Pfizer Europe MA EEIG

Boulevard de la Plaine 17

1050 Bruxelles

Belgium

Manufacturer

Pfizer Service Company BVBA

Hoge Wei 10

1930 Zaventem

Belgium

For any information about this me Authorisation Holder:

please contact the local representative of the Marketing

België/Belgique/Belgien

Pfizer S.A. / N.V.

Tél/Tel: +32 (0)2 554 62 11

Lietuva

Pfizer Luxembourg SARL filialas Lietuvoje

Tel. +3705 2514000

Efc^rapufl n$aň3ep ^ Khoh Bmf;

6ypr CÀP^,

Luxembourg/Luxemburg

Pfizer S.A. / N.V.

Tél/Tel: +32 (0)2 554 62 11

Česká republika

Pfizer, spol. s r.o.

Tel: +420 283 004 111

Magyarország

Pfizer Kft.

Tel: +36 1 488 3700

Danmark

Pfizer ApS

Tlf: +45 44 20 11 00

Malta

Vivian Corporation Ltd

Tel: +35621 344610

Deutschland

Pfizer Pharma GmbH

Tel: +49 (0)30 550055-51000

Nederland

Pfizer bv

Tel: +31 (0)10 406 43 01

Eesti

Pfizer Luxembourg SARL Eesti filiaal

Tel: +372 666 7500

Norge

Pfizer AS

Tlf: +47 67 526 100

EÀÀàôa

PFIZER EAAAZ A.E.

TqX.: +30 210 67 85 800

España

Pfizer, S.L.

Tel: +34 91 490 99 00

France

Pfizer

Tél +33 (0)1 58 07 34 40

Hrvatska

Pfizer Croatia d.o.o.

Tel: +385 1 3908 777

Österreich

Pfizer Corporation Austria Ges.m.b.H.

Tel: +43 (0)1 521 15-0

Polska

Pfizer Polska Sp. z o.o.

Tel.: +48 22 335 61 00

Portugal

Laboratórios Pfizer, Lda.

Tel: (+351) 21 423 55 00

Româ

Pfizer Romania S.R.L

Ireland

Pfizer Healthcare Ireland

Tel: +1800 633 363 (toll free)

Tel: +44 (0)1304 616161

Italia

Pfizer S.r.l.

Tel: +3

Ísland

Icepharma hf.

Tel: +354 540 8000

Kùnpi

PFIZER EAAAZ A.E. (CYPRUS BRANCH)

Trik +357 22 817690

Slovenija

Pfizer Luxembourg SARL

Pfizer, podružnica za svetovanje s področja farmacevtske dejavnosti, Ljubljana

Tel: +386 (0)1 52 11 400

Slovenská republika

Pfizer Luxembourg SARL, organizačná zložka

Tel: +421 2 3355 5500

Suomi/Finland

Pfizer Oy

Puh/Tel: +358 (0)9 430 040

Sverige

Pfizer AB

Tel: +46 (0)8 550 520 00

Latvija

Pfizer Luxembourg SARL filiale Latvijä

Tel. +371 67035775

United Kingdom (Northern Ireland)

Pfizer Limited

Tel: +44 (0)1304 616161

This leaflet was last revised in

Detailed information on this medicine is available on the European Medicines Agency web site: http : //www .ema.europa.eu.

29

About this document

Source: European Medicines Agency (EMA)

Našli jste chybu? Napište nám na info@nonstop-lekarna.cz.

The information on this site does not replace the advice of a doctor or pharmacist.